Rensselaer Polytechnic Institute (RPI) has a long history of training the next generation for career preparedness. With signing of the $250 billion CHIPS and Science Act, the U.S. need for career preparedness has never been greater. The new BYOND – Build Your Own NanoDevice — curriculum at RPI is an interdisciplinary program that invites students from the School of Engineering and the School of Science to work side by side in the lab and classroom. The increasing demand for nanotechnology and semiconductors creates a need for more advanced cleanroom operations. At RPI, the Micro and Nanofabrication Clean Room (MNCR) facility within the Center for Materials, Devices, and Integrated Systems (CMDIS) is offering the BYOND program for undergraduate students to start building a foundation and training for this career path. 

Researchers at Rensselaer Polytechnic Institute (RPI) have been awarded one of 12 grants for space biology research that will advance NASA’s understanding of how organisms respond, acclimate, and adapt in space. These projects will all support NASA’s human space exploration project. 

Shifting customer shopping habits, exacerbated by the recent pandemic, have forced retailers to reimagine the way goods and services are handled. “Omni-channel services” — such as buy online and pickup in store, in-store returns, ship from store, and home delivery — have shifted the in-store logistics once done by shoppers to retailers.

Researchers at Rensselaer Polytechnic Institute (RPI) have published research in Molecular Pharmaceuticals predicting how proteins interact in drug development. The research, funded by the National Science Foundation (NSF), is in collaboration with Amgen and University of Michigan – Ann Arbor. In the paper, researchers use a mathematical model to predict the viscosity of solutions of proteins to be used as drugs. This is critical in drug development as the viscosity determines the method of delivery — needle or IV.

In a perspective article published today in Nature Machine Intelligence, researchers at Rensselaer Polytechnic Institute (RPI) Drs. Ge Wang, Pingkun Yan, and Chuang Niu presented “Medical Technology and AI (MeTAI)” in the metaverse that promises to develop new intelligent health care. This represents a multidisciplinary collaboration among academic and clinical researchers with University of Chicago, Johns Hopkins University, Stony Brook University, industrial leaders from GE Healthcare and Canon Medical Research, and regulatory experts at the FDA and Puente Solutions.

Rensselaer Polytechnic Institute will launch the Douglas A. Mercer ’77 Innovation and Exploration Laboratory at 10:30 a.m. on November 9 at the Russell Sage Dining Hall. Affectionately called the Mercer XLab, the facility aims to facilitate innovation in pedagogy and multiply learning opportunities by fostering interconnection among students and faculty. Mercer, a longtime supporter of his alma mater, originally made possible the Mercer Student Exploration Laboratory. Now, thanks to a $2 million gift, the laboratory is expanding in scope.

A team of researchers led by Rensselaer Polytechnic Institute’s Edwin Fohtung, associate professor of materials science and engineering, has combined expertise in mathematics and condensed matter physics with technological advances to discover new properties of magnetic ferroelectric materials.  

Systems engineers and social scientists at Rensselaer Polytechnic Institute (RPI) and Worcester Polytechnic Institute (WPI) have been awarded $1.85 million by the National Science Foundation (NSF) in the Future of Work program.

Scientists at Rensselaer Polytechnic Institute (RPI), through biomolecular research and testing, have discovered a potential topical therapeutic to treat monkeypox. 

Autism Spectrum Disorder (ASD) is a “blanket” diagnosis applied to individuals with vastly differing behavioral as well as co-occurring medical conditions.  Using very large medical-record data sets, researchers from Rensselaer Polytechnic Institute (RPI) have found that, not only can children be broken into subgroups based upon those co-occurring conditions, but that those subgroups are also associated with differing maternal prenatal risk factors. The research is published today in the journal Autism Research.